In our first interview, we sit down with Jeff Hudson, our Sales Manager for the North East US, who has been an integral part of the Lexogen team since 2017. With two decades of diverse industry experience, Jeff reflects on the unique rewards of selling QuantSeq and shares a memorable success story that highlights its undeniable effectiveness.
“Being a part of Lexogen is truly rewarding for several reasons. One reason is the company’s dedication to producing the best products available for the RNA-Seq marketplace and the support structure in place to assist customers. Another is the more immediate gratification of receiving an order within hours/days of an initial discussion with a customer. My previous experience is selling capital equipment where the order process is typically 6 months to a year after initial discussions with a customer. One memorable story I often share revolves around a customer interested in QuantSeq for gene expression work. However, his team thought they needed more than just gene expression data, so I asked him to keep track of what was actually being done. After a while, he reached out to me himself, acknowledging, “You were right. Most of our studies are only about gene expression”. Despite initial hesitations, he discovered that QuantSeq, with its swift sequencing capabilities, provided more relevant information. Today, he’s a happy QuantSeq user, realizing the efficiency and value it brings. What sets this product apart for me is its undeniable effectiveness. I’ve dealt with various customers, including academics, pharmaceutical companies, biotech, and government agencies, and across the board, it delivers. In the long run, it not only saves customers money and time but also provides the essential information they need. It’s that simple.”